Immunotherapy with and without radiotherapy following the diagnosis of bone metastasis for stage IV non-small cell carcinoma.

J Cancer Res Clin Oncol · 2025 · PMC12575909 · PMID 41165912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

In the patients with stage IV NSCLC with SCC-NOS histology, radiotherapy was associated with significantly improved 3-month survival in the matched cohort and borderline significant results at 6 months, while 1-year survival was similar between groups.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.